Download PDF
Semin Thromb Hemost 2000; 26(5): 571-588
DOI: 10.1055/s-2000-13214
Copyright © 2000 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

LPS and Cytokine-Activated Endothelium

Angelika Bierhaus, Jiang Chen, Birgit Liliensiek, Peter P. Nawroth
  • Department of Medicine IV, Section of Vascular Medicine, University of Tübingen, Tübingen, Germany
Further Information

Publication History

Publication Date:
31 December 2000 (online)

    Permissions and Reprints

ABSTRACT

Endothelial cells coordinate the recruitment of inflammatory cells to sites of vascular injury. Endothelial cells produce and release cytokines and growth factors serving as communication signals to leukocytes as well as with organs and tissues. In addition, endothelial cells respond to inflammatory stimuli such as lipopolysaccharides (endotoxin, LPS), cytokines, or ligation of CD40. Functional changes in response to inflammatory stimuli are mediated by induction of signaling cascades leading to activation of transcription factors and alterations in endothelial gene expression. This article summarizes the current knowledge of molecular events resulting in cytokine-mediated endothelial dysfunction.

KEYWORD

NF-κB - inflammation - TNF-α - CD40 - apoptosis

REFERENCES

  • 1 Stern D M, Bank I, Nawroth P P. Self-regulation of procoagulant events on the endothelial cell surface.  J Exp Med . 1985;  162 1223-1235
    CrossrefPubMedGoogle Scholar
  • 2 Nawroth P P, Bank I, Handley D. Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin-1.  J Exp Med . 1986;  163 1363-1375
    CrossrefPubMedGoogle Scholar
  • 3 Bevilacqua M P, Pober J S, Manjeau G R. Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: Characterization and comparison with the action of interleukin-1.  Proc Natl Acad Sci USA . 1986;  83 4533-4537
    CrossrefPubMedGoogle Scholar
  • 4 Pober J S. Effects of tumour necrosis factor and related cytokines on vascular endothelial cells.  Ciba Found Symp . 1987;  131 170-184
    PubMedGoogle Scholar
  • 5 Sieff C A, Niemeyer C M, Faller D V. Human colony-stimulating factors and stromal cell function.  Soc Gen Physiol Ser . 1988;  43 47-55
    PubMedGoogle Scholar
  • 6 Modat G, Dornand J, Bernad N. LPS-stimulated bovine aortic endothelial cells produce IL-1 and IL-6 like activities.  Agents Actions . 1990;  30 403-411
    PubMedGoogle Scholar
  • 7 Mantovani A, Bussolino F, Dejana E. Cytokine regulation of endothelial cell function.  FASEB J . 1992;  6 2591-2599
    PubMedGoogle Scholar
  • 8 Schonbeck U, Mach F, Bonnefoy J Y. Ligation of CD40 activates interleukin 1 beta-converting enzyme (caspase-1) activity in vascular smooth muscle and endothelial cells and promotes elaboration of active interleukin 1 beta.  J Biol Chem . 1997;  272 19569-19574
    CrossrefPubMedGoogle Scholar
  • 9 Krishnaswamy G, Kelley J, Yerra L, Smith K J, Chi D S. Human endothelium as a source of multifunctional cytokines: Molecular regulation and possible role in human disease.  J Interferon Cytokine Res . 1999;  19 91-104
    CrossrefPubMedGoogle Scholar
  • 10 Murdoch C, Monk P N, Finn A. Cxc chemokine receptor expression on human endothelial cells.  Cytokine . 1999;  11 704-712
    CrossrefPubMedGoogle Scholar
  • 11 Delvos U, Janssen B, Müller-Berghaus G. Effect of lipopolysaccharides on cultured human endothelial cells. Relationship between tissue factor activity and prostacyclin release.  Blut . 1987;  55 101-108
    PubMedGoogle Scholar
  • 12 Henn V, Slupsky J R, Grafe M. CD40 ligand on activated platelets triggers an inflammatory reaction in endothelial cells.  Nature . 1998;  391 591-594
    Google Scholar
  • 13 Slupsky J R, Kalbas M, Willuweit A. Activated platelets induce tissue factor expression on human umbilical vein endothelial cells by ligation of CD40.  Thromb Haemost . 1998;  80 1008-1014
    PubMedGoogle Scholar
  • 14 Howells G, Pham P, Taylor D, Foxwell B, Feldmann M. Interleukin 4 induces interleukin 6 production by endothelial cells: Synergy with interferon-gamma.  Eur J Immunol . 1991;  21 97-101
    PubMedGoogle Scholar
  • 15 Romano M, Sironi M, Toniatti C. Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment.  Immunity . 1997;  6 315-325
    CrossrefPubMedGoogle Scholar
  • 16 Gerszten R E, Garcia-Zepeda E A, Lim Y C. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions.  Nature . 1999;  39 718-723
    PubMedGoogle Scholar
  • 17 Schwartz D, Andalibi A, Chaverri-Almada L. Role of the GRO family of chemokines in monocyte adhesion to MM-LDL-stimulated endothelium.  J Clin Invest . 1994;  94 1968-1973
    CrossrefPubMedGoogle Scholar
  • 18 Ranta V, Orpana A, Carpen O. Human vascular endothelial cells produce tumor necrosis factor-α in response to proinflammatory cytokine stimulation.  Crit Care Med . 1999;  27 2184-2187
    PubMedGoogle Scholar
  • 19 Sironi M, Breviario F, Proserpio P. IL-1 stimulates IL-6 production in endothelial cells.  Immunology . 1989;  142 549-553
    PubMedGoogle Scholar
  • 20 Yue T L, Ni J, Romanic A M. TL-1, a novel tumor necrosis factor-like cytokine, induces apoptosis in endothelial cells. Involvement of activation of stress protein kinases (stress-activated protein kinase and p38 mitogen-activated protein kinase and caspase-3-like-protease).  J Biol Chem . 1999;  274 1479-1486
    CrossrefPubMedGoogle Scholar
  • 21 Zhai Y, Ni J, Jiang G W. VEGI, a novel cytokine of the tumor necrosis family is an angiogenesis inhibitor that suppresses the growth of colon carcinoma in vivo.  FASEB J . 1999;  13 181-189
    PubMedGoogle Scholar
  • 22 Baeuerle P A, Baichwal V R. NF-κB as frequent target for immunosuppressive and antiinflammatory molecules.  Adv Immunol . 1997;  65 111-137
    PubMedGoogle Scholar
  • 23 Barnes P J, Karin M. Nuclear factor-κB: A pivotal transcription factor in chronic inflammatory diseases.  N Engl J Med . 1997;  336 1066-1071
    CrossrefPubMedGoogle Scholar
  • 24 Thurberg B L, Collins T. The nuclear factor-κB/inhibitor of kappa B autoregulatory system and atherosclerosis.  Curr Opin Lipid . 1998;  9 387-396
    PubMedGoogle Scholar
  • 25 Baeuerle P A. Proinflammatory signaling: Last pieces in the NF-κB puzzle?.  Curr Biol . 1998;  8 R19-R22
    CrossrefPubMedGoogle Scholar
  • 26 Baeuerle P A, Baltimore D. NF-κB: Ten years after.  Cell . 1996;  87 13-20
    CrossrefPubMedGoogle Scholar
  • 27 Baeuerle P A, Henkel T. Function and activation of NF-κB in the immune system.  Annu Rev Immunol . 1994;  12 141-179
    CrossrefPubMedGoogle Scholar
  • 28 Read M A, Whitley M Z, Williams A J, Collins T. NF-kappa B and I kappa B alpha: An inducible regulatory system in endothelial activation.  J Exp Med . 1994;  179 503-512
    CrossrefPubMedGoogle Scholar
  • 29 Collins T, Read M, Neish A. Transcriptional regulation of endothelial adhesion molecules: NF-κB and cytokine-inducible enhancers.  FASEB J . 1995;  9 899-909
    PubMedGoogle Scholar
  • 30 Bierhaus A, Zhang Y, Deng Y. Mechanism of the TNFα mediated induction of endothelial tissue factor.  J Biol Chem . 1995;  270 26419-26432
    CrossrefPubMedGoogle Scholar
  • 31 Introna M, Mantovani A. Early activation signals in endothelial cells: Stimulation by cytokines.  Arterioscler Thromb Vasc Biol . 1997;  17 423-428
    PubMedGoogle Scholar
  • 32 Schuhmann R R, Leong S R, Flaggs G W. Structure and function of lipopolysaccharide binding protein.  Science . 1990;  249 1429-1431
    PubMedGoogle Scholar
  • 33 Wright S D, Ramos R A, Tobias P S, Ulevitch R J, Mathison C D. CD14, a receptor for complexes of lipopolysaccharides (LPS) and LPS binding protein.  Science . 1990;  249 1431-1433
    CrossrefPubMedGoogle Scholar
  • 34 Durieux J J, Vita N, Opescu O. The two soluble forms of the lipopolysaccharide receptor, CD14: Characterization and release by normal human monocytes.  Eur J Immunol . 1994;  24 2006-2012
    PubMedGoogle Scholar
  • 35 Pugin J, Ulevitch R J, Tobias P S. A critical role of monocytes and CD 14 in endotoxin-induced endothelial cell activation.  J Exp Med . 1993;  178 2193-2200
    CrossrefPubMedGoogle Scholar
  • 36 Read M A, Cordle S R, Veach R A, Carlisle C D, Hawiger J. Cell-free pool of CD14 mediates activation of transcription factor NF-κB by lipopolysaccharide in human endothelial cells.  Proc Natl Acad Sci USA . 1993;  90 9887-9891
    PubMedGoogle Scholar
  • 37 Ulevitch R J, Tobias P S. Recognition of endotoxin by cells leading to transmembrane signaling.  Curr Opin Immunol . 1994;  6 125-129
    CrossrefPubMedGoogle Scholar
  • 38 Noel Jr F R, Sato T T, Mendez C, Johnson M C, Pohlmann T H. Activation of human endothelial cells by viable or heat-killed gram-negative bacteria requires soluble CD14.  Infect Immunol . 1995;  63 4046-4053
    PubMedGoogle Scholar
  • 39 Pugin J, Ulevitch R J, Tobias P S. Activation of endothelial cells by endotoxin: Direct versus indirect pathways and the role of CD14.  Prog Clin Biol Res . 1995;  392 369-373
    PubMedGoogle Scholar
  • 40 Pugin J, Ulevitch R J, Tobias P S. Tumor necrosis factor-alpha and interleukin-1 beta mediate human endothelial cell activation in blood at low endotoxin concentrations.  J Inflamm . 1995;  45 49-55
    PubMedGoogle Scholar
  • 41 Golenbock D T, Bach R R, Lichenstein H. Soluble CD14 promotes LPS activation of CD14-deficient PNH monocytes and endothelial cells.  J Lab Clin Med . 1995;  125 662-671
    PubMedGoogle Scholar
  • 42 Arditi M, Zhou J. Differential antibiotic-induced endotoxin release and interleukin-6 production by human umbilical vein endothelial cells (HUVECs): Amplification of the response by coincubation of HUVEC and blood cells.  J Infect Dis . 1997;  175 1255-1258
    PubMedGoogle Scholar
  • 43 Arditi M, Zhou J, Torres. Lipopolysaccharide stimulates the tyrosine phosphorylation of mitogen-activated protein kinases p44, p42 and p41 in vascular endothelial cells in a soluble CD14-dependent manner.  J Immunol . 1995;  155 3994-4003
    PubMedGoogle Scholar
  • 44 Arditi M, Zhou J, Dorio R. Endotoxin-mediated endothelial cell injury and activation: role of soluble CD14.  Infect Immunol . 1993;  61 3149-3156
    PubMedGoogle Scholar
  • 45 Herrera-Velit P, Knutson K L, Reiner N E. Phosphatidylinositol 3-kinase-dependent activation of protein kinase c-zeta in bacterial lipopolysaccharide-treated human monocytes.  J Biol Chem . 1997;  272 16445-16452
    CrossrefPubMedGoogle Scholar
  • 46 MacKichan M L, DeFranco A L. Role of ceramide in lipopolysaccharide (LPS)-induced signaling. LPS increases ceramide rather than acting as a structural homolog.  J Biol Chem . 1999;  274 1767-1775
    CrossrefPubMedGoogle Scholar
  • 47 Zhang F X, Kirschning C J, Mancinelli R. Bacterial lipopolysaccharide activates nuclear factor-kappa B through interleukin-1 signaling mediators in cultured human dermal endothelial cells and mononuclear phagocytes.  J Biol Chem . 1999;  274 7611-7614
    PubMedGoogle Scholar
  • 48 Delude R L, Savedra Jr R, Zhao H. CD14 enhances cellular response to endotoxin without imparting ligand-specific recognition.  Proc Natl Acad Sci USA . 1995;  92 9288-9292
    PubMedGoogle Scholar
  • 49 Ingalls R R, Golenbock D T. CD11c/CD18, a transmembrane signaling receptor for lipopolysaccharide.  J Exp Med . 1995;  181 1473-1479
    CrossrefPubMedGoogle Scholar
  • 50 Mukaida N, Ishikawa Y, Ikeda N. Novel insights into molecular mechanism of endotoxin shock: Biochemical analysis of LPS receptor signaling in a cell-free system targeting NF-κB and regulation of cytokine production through beta2 integrin in vivo.  J Leukoc Biol . 1996;  59 145-151
    PubMedGoogle Scholar
  • 51 Ingalls R R, Arnaout M A, Golenbock D T. Outside-in signaling by lipopolysaccharide through a tail-less integrin.  J Immunol . 1997;  159 433-439
    PubMedGoogle Scholar
  • 52 Ingalls R R, Monks B G, Savedra Jr R. CD11/CD18 and CD14 share a common lipid A signaling pathway.  J Immunol . 1998;  161 5413-5420
    PubMedGoogle Scholar
  • 53 Haziot A, Katz I, Rong G W. Evidence that the receptor for soluble CD14:LPS complexes may not be the putative signal-transducing molecule associated with membrane-bound CD14.  Scand J Immunol . 1997;  46 242-245
    CrossrefPubMedGoogle Scholar
  • 54 Kirschning C J, Wesche H, Merrill Ayres T, Rothe M. Human toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide.  J Exp Med . 1998;  188 2091-2097
    CrossrefPubMedGoogle Scholar
  • 55 Yang R B, Mark M R, Gurney A L, Godowski P J. Signaling events induced by lipopolysaccharide-activated toll-like receptor 2.  J Immunol . 1999;  163 639-643
    PubMedGoogle Scholar
  • 56 Lomaga M A, Yeh W C, Sarosi I. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling.  Genes Dev . 1999;  13 1015-1024
    PubMedGoogle Scholar
  • 57 Joseph C K, Wright S D, Bornmann W G. Bacterial lipopolysaccharide has structural similarity to ceramide and stimulates ceramide-activated protein kinase in myeloid cells.  J Biol Chem . 1994;  269 17606-17611
    PubMedGoogle Scholar
  • 58 de-Martin R, Vanhove B, Cheng Q. Cytokine-inducible expression in endothelial cells of an I kappa B alpha-like gene is regulated by NF kappa B.  EMBO J . 1993;  12 2773-2779
    PubMedGoogle Scholar
  • 59 Zabel U, Henkel T, Silva M S, Baeuerle P A. Nuclear uptake control of NF-kappa B by MAD-3, an I kappa B protein present in the nucleus.  EMBO J . 1993;  12 201-211
    PubMedGoogle Scholar
  • 60 Böhrer H, Qiu F, Zimmermann T. Role of NF-κB in the mortality of sepsis.  J Clin Invest . 1997;  100 972-985
    PubMedGoogle Scholar
  • 61 Bannerman D D, Sathyamoorthy M, Goldblum S E. Bacterial lipopolysaccharide disrupts endothelial monolayer integrity and survival signaling events through caspase cleavage of adherens junction proteins.  J Biol Chem . 1998;  273 35371-35380
    CrossrefPubMedGoogle Scholar
  • 62 Bannerman D D, Goldblum S E. Direct effects of endotoxin on the endothelium: barrier function and injury.  Lab Invest . 1999;  79 1118-1199
    PubMedGoogle Scholar
  • 63 Wang J H, Redmont H P, Watson R W, Bouchier-Hayes D. Induction of human endothelial cell apoptosis requires both heat shock and oxidative stress responses.  Am J Physiol . 1997;  272 C1543-C1551
    PubMedGoogle Scholar
  • 64 Koide N, Abe K, Narita K. Apoptotic cell death of vascular endothelial cells and renal tubular cells in the generalized Shwartzman reaction.  FEMS Immunol Med Microbiol . 1996;  16 205-211
    PubMedGoogle Scholar
  • 65 Messmer U K, Briner V A, Pfeilschifter J. Tumor necrosis factor-alpha and lipopolysaccharide induce apoptotic cell death in bovine glomerular endothelial cells.  Kidney Int . 1999;  55 232-2337
    PubMedGoogle Scholar
  • 66 Pohlmann T H, Harlan J M. Human endothelial cell response to lipopolysaccharide, interleukin-1 and tumor necrosis factor is regulated by protein synthesis.  Cell Immunol . 1989;  119 41-52
    CrossrefPubMedGoogle Scholar
  • 67 Marx P T, Mulder A B, Van Den Bergh A F. Apoptosis inducers endotoxin and Fas-ligation enhance the expression of vascular endothelial growth factor in human endothelial cells.  Endothelium . 1999;  6 335-340
    PubMedGoogle Scholar
  • 68 Choi K B, Wong F, Harlan J M. Lipopolysaccharide mediates endothelial apoptosis by a FADD-dependent pathway.  J Biol Chem . 1998;  273 20185-20188
    PubMedGoogle Scholar
  • 69 Beutler B, Cerami A. Cachectin and tumour necrosis factor as two sides of the same biological coin.  Nature . 1986;  320 584-588
    CrossrefPubMedGoogle Scholar
  • 70 Boillot A, Capellier G, Racadot E. Pilot clinical trial of an anti-TNF alpha monoclonal antibody for the treatment of septic shock.  Clin Intensive Care . 1995;  6 52-56
    PubMedGoogle Scholar
  • 71 Van Zee K, Moldawer L, Oldenburg H. Protection against lethal Escherichia coli bacteremia in baboons (Papio anubis) by pretreatment with a 55-kD TNF receptor (CD120a)-Ig fusion protein, Ro 45-2081.  J Immunol . 1996;  156 2221-2230
    PubMedGoogle Scholar
  • 72 Russel D A, Tucker K K, Chinookoswong N, Thompson R C, Kohno T. Combined inhibition of interleukin-1 and tumor necrosis factor in rodent endotoxemia: improved survival and organ function.  J Infect Dis . 1995;  171 1528-1538
    PubMedGoogle Scholar
  • 73 Pfeffer K, Matsuyama T, Kundig T M. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection.  Cell . 1993;  73 457-467
    CrossrefPubMedGoogle Scholar
  • 74 Rothe J, Lesslauer H, Lotscher Y. Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity, but highly susceptible to infection by Listeria monocytogenes.  Nature . 1993;  364 798-802
    PubMedGoogle Scholar
  • 75 Eigler A, Sinha B, Hartmann G, Endres S. Taming TNF: Strategies to restrain the proinflammatory cytokine.  Immunol Today . 1997;  18 487-492
    CrossrefPubMedGoogle Scholar
  • 76 Tewari M, Dixit V. Recent advances in tumor necrosis factor and CD40 signaling.  Curr Opin Genet Dev . 1996;  6 39-44
    CrossrefPubMedGoogle Scholar
  • 77 Grell M, Douni E, Wajant H. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor.  Cell . 1995;  83 793-802
    CrossrefPubMedGoogle Scholar
  • 78 Haas E, Grell M, Wajant H, Scheurich P. Continuous autotropic signaling by membrane-expressed tumor necrosis factor.  J Biol Chem . 1999;  274 18107-18112
    CrossrefPubMedGoogle Scholar
  • 79 Rothe M, Sarma V, Dixit V M, Goeddel D V. TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40.  Science . 1995;  269 1424-1427
    PubMedGoogle Scholar
  • 80 Shu H B, Takeuchi M, Goeddel D V. The tumor necrosis factor receptor 2 signal transducers TRAF2 and c-IAP1 are components of the tumor necrosis factor receptor 1 signaling complex.  Proc Natl Acad Sci USA . 1996;  93 13973-13978
    CrossrefPubMedGoogle Scholar
  • 81 Declercq W, Denecker G, Fiers W, Vandenabeele P. Cooperation of both TNF receptors in inducing apoptosis: Involvement of the TNF receptor-associated factor binding domain of the TNF receptor 75.  Immunology . 1998;  161 390-399
    PubMedGoogle Scholar
  • 82 Mercurio F, Zhu H, Murray B W. IκK-1 and IκK-2: Cytokine activated IκB kinases essential for NF-κB activation.  Science . 1997;  278 860-866
    CrossrefPubMedGoogle Scholar
  • 83 Bennett B L, Lacson R G, Chen C C. Identification of signal-induced IκBα-kinases in human endothelial cells.  J Biol Chem . 1996;  271 19680-19688
    CrossrefPubMedGoogle Scholar
  • 84 Cohen L, Henzel W J, Baeuerle P A. IKAP is a scaffold protein of the IkappaB kinase complex.  Nature . 1998;  395 292-296
    CrossrefPubMedGoogle Scholar
  • 85 Rothwarf D M, Zandl E, Natoli G, Karin M. IKK-gamma is an essential regulatory subunit of the IkappaB kinase complex.  Nature . 1998;  395 297-300
    CrossrefPubMedGoogle Scholar
  • 86 Scheidereit C. Docking IκB kinases.  Nature . 1998;  395 225-226
    CrossrefPubMedGoogle Scholar
  • 87 Read M A, Neish A S, Luscinskas F W. The proteasome pathway is required for cytokine-induced endothelial-leukocyte adhesion molecule expression.  Immunity . 1995;  2 493-506
    CrossrefPubMedGoogle Scholar
  • 88 Johnson D R, Douglas A, Jahnke J, Ghosh S, Pober J S. A sustained reduction in IκB-β may contribute to persistent NF-κB activation in human endothelial cells.  J Biol Chem . 1996;  271 16317-16322
    CrossrefPubMedGoogle Scholar
  • 89 Suyang H, Phillips H R, Douglas I, Ghosh S. Role of unphosphorylated, newly synthesized IκBβ in persistent activation of NF-κB.  Mol Cell Biol . 1996;  16 5444-5449
    PubMedGoogle Scholar
  • 90 Modur V, Zimmerman G A, Prescott S M, McIntyre T M. Endothelial cell inflammatory response to TNFα: Ceramide-dependent and independent mitogen activated protein kinase cascades.  J Biol Chem . 1996;  271 13094-13102
    CrossrefPubMedGoogle Scholar
  • 91 Mantovani A, Sozzani S, Vecci A, Introna M, Allavena P. Cytokine activation of endothelial cells: New molecules for an old paradigm.  Thromb Haemost . 1997;  78 406-414
    PubMedGoogle Scholar
  • 92 Karin M. The regulation of AP-1 activity by mitogen-activated protein kinases.  J Biol Chem . 1995;  270 16483-16486
    PubMedGoogle Scholar
  • 93 Karin M, Delhase M. JNK or IKK, AP-1 or NF-κB, which are the targets for MEK kinase 1 action?.  Proc Natl Acad Sci USA . 1998;  95 9067-9069
    CrossrefPubMedGoogle Scholar
  • 94 Angel P E, Karin M. The role of jun, Fos and the AP-1 complex in cell proliferation and transformation.  Biochem Biophys Res Commun . 1991;  1072 129-157
    PubMedGoogle Scholar
  • 95 Kaszubska W, Hooft von Huijsduijnen R, Ghersa P. Cyclic AMP-independent ATF family members interact with NF-κB and function in the activation of the E-selectin promoter in response to cytokines .  Mol Cell Biol . 1993;  13 7180-7190
    PubMedGoogle Scholar
  • 96 Haimovitz-Friedman A, Cordon-Cardo C, Bayoumy S. Lipopolysaccharide induces disseminated endothelial apoptosis requiring ceramide generation.  J Exp Med . 1997;  186 1831-1841
    CrossrefPubMedGoogle Scholar
  • 97 Chinnayaian A M, O'Rourke K, Tewari M, Dixit V. FADD, a novel death domain-containing protein interacts with the death domain of Fas and initiates apoptosis.  Cell . 1995;  81 501-512
    PubMedGoogle Scholar
  • 98 Hsu H, Shu H B, Pan M G, Goeddel D V. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor-1 signal transduction pathways.  Cell . 1996;  84 299-308
    CrossrefPubMedGoogle Scholar
  • 99 Pober J S. Activation and injury of endothelial cells by cytokines.  Pathol Biol (Paris) . 1998;  46 159-163
    PubMedGoogle Scholar
  • 100 Fuks Z, Persaud A, Alfieri A. Basic fibroblast growth factor protects endothelial cells against radiation-induced programmed cell death in vitro and in vivo.  Cancer Res . 1994;  54 2582-2590
    PubMedGoogle Scholar
  • 101 Reul R M, Fang J C, Denton M D. CD40 and CD40 ligand (CD154) are coexpressed on microvessels in vivo in human cardiac allograft rejection.  Transplantation . 1997;  64 1765-1774
    PubMedGoogle Scholar
  • 102 Mach F, Schonbeck U, Sukhova G K. Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: Implications for CD40-CD40 ligand signaling in atherosclerosis.  Proc Natl Acad Sci USA . 1997;  94 1931-1936
    CrossrefPubMedGoogle Scholar
  • 103 Mach F, Schonbeck U, Libby P. CD40 signalling in vascular cells: A key role in atherosclerosis?.  Atherosclerosis . 1998;  137(Suppl) S89-S95
    CrossrefPubMedGoogle Scholar
  • 104 Yellin M J, Brett J, Baum D. Functional interactions of T cells with endothelial cells: The role of CD40L-CD40-mediated signals.  J Exp Med . 1995;  182 1857-1864
    CrossrefPubMedGoogle Scholar
  • 105 Zhou L, Stordeur P, de Lavareille A. CD40 engagement on endothelial cells promotes tissue factor dependent procoagulant activity.  Thromb Haemost . 1998;  79 1025-1028
    PubMedGoogle Scholar
  • 106 Hollenbaugh D, Mischel Petty N, Edwards C P. Expression of functional CD40 by vascular endothelial cells.  J Exp Med . 1995;  182 33-40
    CrossrefPubMedGoogle Scholar
  • 107 Krzesz R, Wagner A, Cattaruzza M, Hecke, M. Cytokine-inducible CD40 gene expression in vascular smooth muscle cells is mediated by nuclear factor κB and signal transducer and activator of transcription-1.  FEBS Lett . 1999;  453 191-196
    CrossrefPubMedGoogle Scholar
  • 108 Dufay N, Reboul A, Touraine-Moulin F, Belin M F, Giraudon P. Soluble factors, including TNFα, secreted by human T cells are both cytotoxic and cytostatic for medulloblastoma cells.  J Neurooncol . 1999;  43 115-126
    CrossrefPubMedGoogle Scholar
  • 109 Murakami K, Ma W, Fuleihan R, Pober J S. Human endothelial cells augment early CD40 ligand expression in activated CD4+ T cells through LFA-3-mediated stabilization of mRNA.  J Immunol . 1999;  163 2667-2673
    PubMedGoogle Scholar
  • 110 Pober J S. Immunobiology of human vascular endothelium.  Immunol Res . 1999;  19 225-232
    PubMedGoogle Scholar
  • 111 Lee H H, Dempsey P, Parks T P. Specificities of CD40 signaling: Involvement of TRAF2 in CD40 induced NF-κB activation and intercellular adhesion molecule-1 up-regulation.  Proc Natl Acad Sci USA . 1999;  96 1421-1426
    CrossrefPubMedGoogle Scholar
  • 112 Tsukamoto N, Kobayashi N, Azuma S, Yamamoto T, Inoue J-I. Two differently regulated nuclear factor κB activation pathways triggered by the cytoplasmic tail of CD40.  Proc Natl Acad Sci USA . 1999;  96 1234-1239
    CrossrefPubMedGoogle Scholar
  • 113 Snapper C M, Rosas F, Moorman M A. IFN-gamma is a potent inducer of Ig secretion by sort-purified murine B cells activated through the mIg, but not the CD40, signaling pathway.  Int Immunol . 1996;  8 877-885
    PubMedGoogle Scholar
  • 114 Chaudhuri A, Orme S, Vo T, Wang W, Cherayil B J. Phosphorylation of TRAF2 inhibits binding to the CD40 cytoplasmic domain.  Biochem Biophys Res Commun . 1999;  256 620-625
    CrossrefPubMedGoogle Scholar
  • 115 Pullen S S, Dang T T, Crute J J, Kehry M R. CD40 signaling through tumor necrosis factor receptor-associated factors (TRAFs). Binding site specificity and activation of downstream pathways by distinct TRAFs.  J Biol Chem . 1999;  274 14246-14254
    CrossrefPubMedGoogle Scholar
  • 116 Sutherland C L, Krebs D L, Gold M R. An 11-amino acid sequence in the cytoplasmic domain of CD40 is sufficient for activation of c-Jun N-terminal kinase, activation of MAPKAP kinase-2, phosphorylation of I kappa B alpha, and protection of EEHI-231 cells from anti-IgM-induced growth arrest.  J Immunol . 1999;  162 4720-4730
    PubMedGoogle Scholar
  • 117 Leo E, Welsh K, Matsutawa S. Differential requirements for tumor necrosis factor receptor-associated factor family proteins in CD40-mediated induction of NF-κB and Jun N-terminal kinase activation.  J Biol Chem. 1999;  274 22414-22422
    CrossrefPubMedGoogle Scholar
  • 118 Karmann K, Min W, Fanslow W C, Pober J S. Activation and homologous desensitization of human endothelial cells by CD40 ligand, tumor necrosis factor and interleukin-1.  J Exp Med . 1996;  184 173-182
    CrossrefPubMedGoogle Scholar
  • 119 Neurath M F, Pettersson S, Meyer zum Büschenfelde K H, Strober W. Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice.  Nature Med . 1996;  2 998-100
    CrossrefPubMedGoogle Scholar
  • 120 Schreiber S, Nikolaus S, Hampe J. Activation of nuclear factor kappa B inflammatory bowel disease.  Gut . 1998;  42 477-484
    CrossrefPubMedGoogle Scholar
  • 121 Thiele K, Bierhaus A, Autschbach F. Cell specific effects of glucocorticoid treatment on the NF-κBp65/IκBα system in patients with Crohn's disease.  Gut . 1999;  45 693-704
    PubMedGoogle Scholar
  • 122 Battaglia E, Biancone L, Resegotti A. Expression of CD40 and its ligand, CD40L, in intestinal lesions of Crohn's disease.  Am J Gastroenterol . 1999;  94 3279-3284
    CrossrefPubMedGoogle Scholar
  • 123 Bussolino F, Camussi G, Tetta C. Selected cytokines promote the synthesis of platelet-activating factor in vascular endothelial cells: Comparison between tumor necrosis factor alpha and beta and interleukin-1.  J Lipid Mediat . 1990;  2 S15-S22
    PubMedGoogle Scholar
  • 124 Koltai M, Hosford D, Braquet P. Role of PAF and cytokines in microvascular tissue injury.  J Lab Clin Med . 1992;  119 461-466
    PubMedGoogle Scholar
  • 125 Andrews R K, Shen Y, Gardiner E E. The glycoprotein Ib-IX-V-complex in platelet adhesion and signaling.  Thromb Haemost . 1999;  82 357-364
    PubMedGoogle Scholar
  • 126 Rock G, Wells P. New concepts in coagulation.  Crit Rev Clin Lab Sci . 1997;  34 475-501
    PubMedGoogle Scholar
  • 127 May A E, Neumann F J, Preissner K T. The relevance of blood cell-vessel wall adhesive interactions for vascular thrombotic disease.  Thromb Haemost . 1999;  82 962-970
    PubMedGoogle Scholar
  • 128 Miller D L, Yaron R, Yellin M J. CD40L-CD40 interactions regulate endothelial cell surface tissue factor and thrombomodulin.  J Leukoc Biol . 1998;  63 373-379
    PubMedGoogle Scholar
  • 129 Bevilacqua M P, Gimbrone Jr A M. Inducible endothelial functions in inflammation and coagulation.  Semin Thromb Hemost . 1987;  13 425-433
    PubMedGoogle Scholar
  • 130 Bevilacqua M P, Stengelin S, Gimbrone M A, Seed B. Endothelial leukocyte adhesion molecule 1: An inducible receptor for neutrophils related to complement regulatory proteins and lectins.  Science . 1989;  243 1160-1165
    PubMedGoogle Scholar
  • 131 Elices M, Osborn L, Takada Y. VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4 fibronectin binding site.  Cell . 1990;  60 577-584
    CrossrefPubMedGoogle Scholar
  • 132 Neish A S, Read M A, Thanos D. Endothelial interferon regulatory factor 1 cooperates with NF-κB as a transcriptional activator of vascular adhesion molecule 1.  Mol Cell Biol . 1995;  15 2558-2569
    PubMedGoogle Scholar
  • 133 Fan S T, Edgington T S. Coupling of the adhesive receptor CD11b/CD18 to functional enhancement of the effector macrophage tissue factor response.  J Clin Invest . 1991;  87 50-57
    PubMedGoogle Scholar
  • 134 Fan S T, Mackman N, Cui M Z, Edgington T. Integrin regulation of an inflammatory effector gene. Direct induction of the tissue factor promoter by engagement of β1 or α4 integrin chains.  J Immunol . 1995;  154 3266-3274
    PubMedGoogle Scholar
  • 135 Nawroth P P, Stern D M. Modulation of endothelial cell hemostatic properties by tumor necrosis factor.  J Exp Med . 1986;  163 740-745
    CrossrefPubMedGoogle Scholar
  • 136 Nawroth P P, Handley D A, Esmon C T, Stern D M. Interleukin 1 induces endothelial cell procoagulant while suppressing cell-surface anticoagulant activity.  Proc Natl Acad Sci USA . 1986;  83 3460-3464
    PubMedGoogle Scholar
  • 137 Bach R R. Initiation of coagulation by tissue factor.  Crit Rev Biochem . 1988;  23 339-348
    PubMedGoogle Scholar
  • 138 Conway E M, Bach R, Rosenberg R, Konigsberg W H. Tumor necrosis factor enhances expression of tissue factor mRNA in endothelial cells.  Thromb Res . 1989;  53 231-241
    CrossrefPubMedGoogle Scholar
  • 139 Camerer E, Kolsto A B, Prydz H. Cell biology of tissue factor, the principal initiator of blood coagulation.  Thromb Res . 1996;  81 1-41
    CrossrefPubMedGoogle Scholar
  • 140 Moll T, Czyz M, Holzmüller H. Regulation of the tissue factor promoter in endothelial cells.  J Biol Chem . 1995;  270 3849-3857
    CrossrefPubMedGoogle Scholar
  • 141 Bierhaus A, Hemmer C J, Mackman N. Antiparasitic treatment of patients with P. falciparum malaria reduces the ability of patient serum to induce tissue factor by decreasing NF-κB activation.  Thromb Haemost . 1955;  73 39-48
    PubMedGoogle Scholar
  • 142 Parry G C, Mackman N. Transcriptional regulation of tissue factor expression in human endothelial cells.  Arterioscler Thromb Vasc Biol . 1995;  15 612-621
    CrossrefPubMedGoogle Scholar
  • 143 Mackman N. Regulation of the tissue factor gene.  Thromb Haemost . 1997;  78 747-754
    PubMedGoogle Scholar
  • 144 Bierhaus A, Zhang Y, Quehenberger P. The dietary pigment curcumin reduces endothelial tissue factor expression by inhibiting binding of AP-1 to the DNA and activation of NF-κB.  Thromb Haemost . 1997;  77 772-782
    PubMedGoogle Scholar
  • 145 Contrino J, Hair G, Kreutzer D L, Rickles F R. In situ detection of tissue factor in vascular endothelial cells: Correlation with the malignant phenotype of human breast disease.  Nature Med . 1996;  2 209-215
    CrossrefPubMedGoogle Scholar
  • 146 Zhang Y, Deng Y, Wendt T. Intravenous somatic gene transfer with antisense tissue factor restores blood flow by reducing tumor necrosis factor induced tissue factor expression and fibrin deposition in mouse Meth-A sarcomas.  J Clin Invest . 1996;  97 2213-2224
    PubMedGoogle Scholar
  • 147 Zhang Y, Deng Y, Luther T. Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice.  J Clin Invest . 1994;  94 1320-1327
    Google Scholar
  • 148 Solovey A, Gui L, Key N S, Hebbel R P. Tissue factor expression by endothelial cells in sickle cell anemia.  J Clin Invest . 1998;  101 1899-1904
    CrossrefPubMedGoogle Scholar
  • 149 Drake T A, Cheng J, Chang A, Taylor Jr B F. Expression of tissue factor, thrombomodulin, and E-selectin in baboons with lethal Escherichia coli sepsis.  Am J Pathol . 1993;  142 1458-1470
    PubMedGoogle Scholar
  • 150 Warr T A, Rao L VM, Rapaport S I. Disseminated intravascular coagulation in rabbits induced by administration of LPS or tissue factor: Effect of anti-tissue factor antibodies and measurement of plasma extrinsic pathway inhibitor activity.  Blood . 1990;  75 1481-1489
    PubMedGoogle Scholar
  • 151 Levi M, ten Cate H, van der Poll T, van Deventer J H S. Pathogenesis of disseminated intravascular coagulation in sepsis.  JAMA . 1993;  270 975-979
    CrossrefPubMedGoogle Scholar
  • 152 Fiedler V B, Loof I, Sander E. Monoclonal antibody to tumor necrosis factor-alpha prevents lethal endotoxin sepsis in adult rhesus monkeys.  J Lab Clin Med . 1992;  120 574-588
    PubMedGoogle Scholar
  • 153 Nawroth P P, Handly G, Matsueda R. Tumor necrosis factor/cachectin-induced intravascular fibrin formation in Meth A fibrosarcomas.  J Exp Med . 1988;  168 637-647
    CrossrefPubMedGoogle Scholar
  • 154 Clauss M, Gerlach M, Gerlach H. Vascular permeability factor: A tumor derived polypeptide that induces endothelial cell and monocyte procoagulant activity and promotes monocyte migration.  J Exp Med . 1990;  172 1535-1545
    CrossrefPubMedGoogle Scholar
  • 155 Clauss M, Murray J C, Vianna M. A polypeptide factor produced by fibrosarcoma cells that induce endothelial tissue factor and enhances the procoagulant response to tumor necrosis factor/cachectin.  J Biol Chem . 1990;  265 7078-7083
    PubMedGoogle Scholar
  • 156 Anrather D, Millan M T, Palmetshofer A. Thrombin activates nuclear factor-kappa B and potentiates endothelial cell activation by TNF.  J Immunol . 1997;  159 5620-5628
    PubMedGoogle Scholar
  • 157 Zhang Y M, Bachmann S, Hemmer C. Vascular origin of Kaposi's sarcoma. Expression of leukocyte adhesion molecule-1, thrombomodulin, and tissue factor.  Am J Pathol . 1994;  144 51-59
    PubMedGoogle Scholar
  • 158 Samaniego F, Markham P D, Gendelmann R, Gallo R C, Ensoli B. Inflammatory cytokines induce endothelial cells to produce and release basic fibroblast growth factor and to promote Kaposi's sarcoma-like lesions in nude mice.  J Immunol . 1997;  158 1887-1894
    PubMedGoogle Scholar
  • 159 von der Ahe D, Nischan C, Kunz C. Ets transcription factor binding site is required for positive and TNF alpha-induced negative promoter regulation.  Nucleic Acids Res . 1993;  21 5636-5643
    PubMedGoogle Scholar
  • 160 Tazawa R, Hirosawa S, Suzuki K, Hirokawa K, Aoki N J. Functional characterization of the 5′-regulatory region of the human thrombomodulin gene.  Biochemistry (Tokyo) . 1993;  113 600-606
    PubMedGoogle Scholar
  • 161 Hayashi T, Nakamura H, Okada A. Organization and chromosomal localization of the human endothelial protein C receptor gene.  Gene . 1999;  238 367-373
    CrossrefPubMedGoogle Scholar
  • 162 Descheemaeker K A, Wyns S, Nelles L. Interaction of AP-1-, AP-2-, and Sp1-like proteins with two distinct sites in the upstream regulatory region of the plasminogen activator inhibitor-1 gene mediates the phorbol 12-myristate 13-acetate response.  J Biol Chem. . 1992;  267 15086-15091
    PubMedGoogle Scholar
  • 163 Esmon C T, Ding W, Yasuhiro K. The protein C pathway: New insights.  Thromb Haemost . 1997;  78 70-74
    PubMedGoogle Scholar
  • 164 Esmon C T. The roles of protein C and thrombomodulin in the regulation of blood coagulation.  J Biol Chem . 1989;  264 4743-4746
    PubMedGoogle Scholar
  • 165 Conway E M, Rosenberg R D. Tumor necrosis factor suppresses transcription of the thrombomodulin gene in endothelial cells.  Mol Cell Biol . 1988;  8 5588-5592
    PubMedGoogle Scholar
  • 166 Böhme M MJ, Deng Y, Räth U. Release of thrombomodulin from endothelial cells by a concerted action of TNFα and neutrophils: In vitro and in vivo studies.  Immunology . 1996;  87 134-140
    PubMedGoogle Scholar
  • 167 Esmon C T, Xu J, Gu J-M. Endothelial protein C receptor.  Thromb Haemost . 1999;  82 251-258
    PubMedGoogle Scholar
  • 168 Powars D, Larsen R, Johnson J. Epidemic meningococcemia and purpura fulminans with induced protein C deficiency.  Clin Infect Dis . 1993;  17 254-261
    PubMedGoogle Scholar
  • 169 Esmon C T, D'Angelo A, Vigano-D'Angelo S, Blick K E. Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon.  J Clin Invest . 1987;  79 918-925
    CrossrefPubMedGoogle Scholar
  • 170 Taylor F B, Chang A, Ruf W. E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody.  Circ Shock . 1991;  33 127-134
    PubMedGoogle Scholar
  • 171 Hancock W W, Tsuchida A, Hau H, Thomson N M, Salem H H. The anticoagulants protein C and protein S display potent antiinflammatory and immunosuppressive effects relevant to transplant biology and therapy.  Transplant Proc . 1992;  24 2302-2303
    PubMedGoogle Scholar
  • 172 Hooper W C, Philipps D J, Evatt B L. Endothelial cell protein S synthesis is upregulated by the complex of IL-6 and soluble IL-6 receptor.  Thromb Haemost . 1997;  77 1014-1019
    PubMedGoogle Scholar
  • 173 Hooper W C, Philipps D J, Renshaw M A, Evatt B L, Benson J M. The up-regulation of IL-6 and IL-8 in human endothelial cells by activated protein C.  J Immunol . 1998;  161 2567-2573
    PubMedGoogle Scholar
  • 174 Levi M, ten Cate H, Bauer K A. Inhibition of LPS-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees.  J Clin Invest . 1994;  93 114-120
    CrossrefPubMedGoogle Scholar
  • 175 Moore K L, Andreoli S P, Esmon N, Esmon C T, Bang N U. Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro.  J Clin Invest . 1987;  79 124-130
    CrossrefPubMedGoogle Scholar
  • 176 Dosne A M, Dubor F, Lutcher F, Parant M, Chedid L. Tumor necrosis factor (TNF) stimulates plasminogen activator inhibitor (PAI) production by endothelial cells and decreases blood fibrinolytic activity in the rat.  Thromb Res (suppl). 1988;  8 115-122
    PubMedGoogle Scholar
  • 177 Westendorp R G, Hottenga J J, Slagboom P E. Variation in plasminogen-activator-inhibitor-1 gene and risk of meningococcal septic shock.  Lancet . 1999;  354 561-563
    CrossrefPubMedGoogle Scholar
  • 178 Gladson C L, Schleef R R, Binder B R, Loskutoff D J, Griffin J H. A comparison between activated protein C and des-1-41-light chain activated protein C in reactions with type-1 plasminogen activator inhibitor.  Blood . 1989;  74 173-181
    PubMedGoogle Scholar
  • 179 Hermanns P WM, Hibberd M L, Booy R. 4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene and outcome of meningococcal disease.  Lancet . 1999;  354 556-560
    CrossrefPubMedGoogle Scholar
  • 180 Lin J, Liliensiek B, Kanitz M. Molecular cloning of genes differentially regulated by TNF-α in bovine aortic endothelial cells, fibroblasts and smooth muscle cells.  Cardiovasc Res . 1998;  38 802-813
    CrossrefPubMedGoogle Scholar
  • 181 Liliensiek B, Rocha M, Umansky V. Identification of four genes in endothelial cells whose expression is affected by tumor cells and host immune status: A study in ex vivo-isolated endothelial cells.  Blood . 1998;  9 3394-3404
    PubMedGoogle Scholar
  • 182 McLaughlin F, Hayes B P, Horgan C M. Tumor necrosis factor (TNF)-alpha and interleukin (IL)-1beta down-regulate intercellular adhesion molecule (ICAM)-2 expression on the endothelium.  Cell Adhes Commun . 1998;  6 381-400
    PubMedGoogle Scholar
  • 183 Kainulainen V, Nelimarkka L, Jarvelainen H. Suppression of syndecan-1 expression in endothelial cells by tumor necrosis factor-1.  J Biol Chem . 1996;  21 18759-18766
    PubMedGoogle Scholar
  • 184 Liliensiek B, Lin J, Fotsis T. Tumor necrosis factor-α controls transcription of connective tissue growth factor in cultured vascular endothelial cells.  (submitted).
    PubMedGoogle Scholar
  • 185 Sata M, Walsh K. TNFα regulation of Fas ligand expression on the vascular endothelium modulates leukocyte extravasation.  Nature Med . 1998;  4 415-420
    PubMedGoogle Scholar
  • 186 Walsh K, Sata M. Is extravasation a Fas-regulated process?.  Mol Med Today . 1999;  5 61-67
    PubMedGoogle Scholar
  • 187 Richardson B C, Lalwani N D, Johnson K J, Marks R M. Fas ligation triggers apoptosis in macrophages but not endothelial cells.  Eur J Immunol . 1994;  24 2640-2645
    PubMedGoogle Scholar
  • 188 Avanzi G C, Gallicchio M, Bottarel F. GAS6 inhibits granulocyte adhesion to endothelial cells Blood .  1998;  91 2334-2340
    PubMedGoogle Scholar
  • 189 O'Donnell K, Harkes I C, Dougherty L, Wicks I P. Expression of receptor tyrosine kinase Axl and its ligand Gas6 in rheumatoid arthritis: Evidence for a novel endothelial cell survival pathway.  Am J Pathol . 1999;  154 1171-1180
    PubMedGoogle Scholar
  • 190 Poss K D, Tongegawa S. Heme oxygenase-1 is required for mammalian iron reutilization.  Proc Natl Acad Sci USA . 1997;  94 10919-10924
    CrossrefPubMedGoogle Scholar
  • 191 Willis D, Moore A R, Frederick R, Willoughby D A. Heme oxygenase: A novel target for the modulation of the inflammatory response.  Nature Med . 1996;  2 87-90
    PubMedGoogle Scholar
  • 192 Terry C M, Clikeman J A, Hoidal J R, Callahan K S. Effect of tumor necrosis factor-alpha and interleukin-1 alpha on heme oxygenase-1 expression in human endothelial cells.  Am J Physiol . 1998;  274 H883-H891
    PubMedGoogle Scholar
  • 193 Yachie A, Niida Y, Wada T. Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency.  J Clin Invest . 1999;  103 129-135
    CrossrefPubMedGoogle Scholar
  • 194 Kwak E L, Larochelle D A, Beaumont C, Torti S V, Torti F M. Role of NF-kappa B in the regulation of ferritin H by tumor necrosis factor-alpha.  J Biol Chem . 1995;  270 15285-15293
    CrossrefPubMedGoogle Scholar
  • 195 Bach F H, Hancock W W, Ferran C. Protective genes expressed in endothelial cell: A regulatory response to injury.  Immunol Today . 1997;  18 483-486
    CrossrefPubMedGoogle Scholar
  • 196 Peng H B, Libby P, Liao J K. Induction and stabilization of I kappa B alpha by nitric oxide mediates inhibition of NF-kappa B.  J Biol Chem . 1995;  270 14214-14219
    CrossrefPubMedGoogle Scholar
  • 197 Scalia R, Booth G, Lefer D J. Vascular endothelial growth factor attenuates leukocyte-endothelium interaction during acute endothelial dysfunction: Essential role of endothelium-derived nitric oxide.  FASEB J . 1999;  13 1039-1046
    PubMedGoogle Scholar
  • 198 Beg A A, Baltimore D. An essential role of NF-κB in preventing TNFα-induced cell death.  Science . 1996;  274 782-784
    CrossrefPubMedGoogle Scholar
  • 199 Soares M P, Muniappan A, Kaczmarek E. Adenovirus-mediated expression of a dominant negative mutant of p65/RelA inhibits proinflammatory gene expression in endothelial cells without sensitizing apoptosis.  J Immunol . 1998;  161 4572-4582
    PubMedGoogle Scholar
  • 200 Zen K, Karsan A, Stempien-Otero A. NF-κB activation is required for human endothelial cell survival during exposure to tumor necrosis factor-alpha but not to interleukin-1 beta or lipopolysaccharide.  J Biol Chem . 1999;  274 28808-28815
    CrossrefPubMedGoogle Scholar
  • 201 Altieri D C. Paracrine control of endothelial cell survival.  J Clin Invest . 1999;  104 845
    PubMedGoogle Scholar
  • 202 Hu X, Yee E, Harlan J M, Wong F, Karsan A. Lipopolysaccharide induces the antiapoptotic molecules A1 and A20 in microvascular endothelial cells.  Blood . 1998;  92 2759-2765
    PubMedGoogle Scholar
  • 203 Cooper J T, Stroka D M, Brostjan C. A20 blocks endothelial cell activation through a NF-kappaB-dependent mechanism.  J Biol Chem . 1996;  271 18068-18073
    CrossrefPubMedGoogle Scholar
  • 204 Xia P, Wang L, Gamble J R, Vadas M A. Activation of sphingosine kinase by tumor necrosis factor-alpha inhibits apoptosis in human endothelial cells.  J Biol Chem . 1999;  274 34499-34505
    CrossrefPubMedGoogle Scholar
  • 205 Stehlik C, de Martin R, Kumabashiri I. Nuclear factor (NF)-kappaB-regulated X-chromosome-linked iap gene expression protects endothelial cells from tumor necrosis factor alpha-induced apoptosis.  J Exp Med . 1998;  188 211-216
    CrossrefPubMedGoogle Scholar
  • 206 Badrichani A Z, Stroka D M, Bilbao G. Bcl-2 and Bcl-Xl serve an anti-inflammatory function in endothelial cells through inhibition of NF-κB.  J Clin Invest . 1999;  103 543-553
    PubMedGoogle Scholar
  • 207 Van Antwerp D, Martin S, Jafri T, Green D, Verma I. Suppression of TNFα-induced apoptosis by NF-κB.  Science . 1996;  274 782-784
    CrossrefPubMedGoogle Scholar
  • 208 Olofsson A M, Vestberg M, Herwald H. Heparin-binding protein targeted to mitochondrial compartments protects endothelial cells from apoptosis.  J Clin Invest . 1999;  104 885-894
    PubMedGoogle Scholar